Voters of a certain persuasion were devastated by last month’s U.S. elections, as one key battleground state after another fell. Unprecedented amounts of money were poured into must-win races, only to fall short. We’re talking, of course, about the defeat of cannabis legalization in several states, especially in Florida, where “activists” spent more than $150 million to pass Amendment 3 to allow recreational sales. Similar efforts failed in both Dakotas (do we really need two?). The lone bright spot: Nebraska voters overwhelmingly approved medical marijuana to become the 39th state to legalize weed for back pain and other “ailments.”
It was not a good night for legalizing it. Credit: Goodwin Law
Sign up to our newsletter to get more of our great research delivered straight to your inbox!
Nanalyze Weekly includes useful insights written by our team of underpaid MBAs, research on new disruptive technology stocks flying under the radar, and summaries of our recent research. Always 100% free.
Become a premium member and get access to hundreds of premium articles, reports and additional content.
Nanalyze Premium is your comprehensive guide to investing in disruptive technologies. Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years.